Myocardial infarction triggers cardioprotective antigen-specific T helper cell responses.
-
Rieckmann M
Department of Internal Medicine III, University Clinic Halle, Halle, Germany.
-
Delgobo M
Department of Internal Medicine I, and.
-
Gaal C
Department of Internal Medicine I, and.
-
Büchner L
Department of Internal Medicine I, and.
-
Steinau P
Department of Internal Medicine III, University Clinic Halle, Halle, Germany.
-
Reshef D
Department of Immunology, Weizmann Institute of Science, Rehovot, Israel.
-
Gil-Cruz C
Institute of Immunobiology, Kantonsspital St. Gallen, St. Gallen, Switzerland.
-
Horst ENT
Heart Center, Amsterdam UMC, location AMC, Amsterdam, Netherlands.
-
Kircher M
Department of Nuclear Medicine, University Hospital Würzburg, Würzburg, Germany.
-
Reiter T
Department of Internal Medicine I, and.
-
Heinze KG
Rudolf Virchow Center for Experimental Biomedicine, University of Würzburg, Würzburg, Germany.
-
Niessen HW
Department of Pathology and Cardiac Surgery, Amsterdam UMC, location VUmc, Amsterdam, Netherlands.
-
Krijnen PA
Department of Pathology and Cardiac Surgery, Amsterdam UMC, location VUmc, Amsterdam, Netherlands.
-
van der Laan AM
Heart Center, Amsterdam UMC, location AMC, Amsterdam, Netherlands.
-
Piek JJ
Heart Center, Amsterdam UMC, location AMC, Amsterdam, Netherlands.
-
Koch C
Department of Internal Medicine III, University Clinic Halle, Halle, Germany.
-
Wester HJ
Pharmaceutical Radiochemistry, Technical University Munich, Munich, Germany.
-
Lapa C
Department of Nuclear Medicine, University Hospital Würzburg, Würzburg, Germany.
-
Bauer WR
Department of Internal Medicine I, and.
-
Ludewig B
Institute of Immunobiology, Kantonsspital St. Gallen, St. Gallen, Switzerland.
-
Friedman N
Department of Immunology, Weizmann Institute of Science, Rehovot, Israel.
-
Frantz S
Department of Internal Medicine III, University Clinic Halle, Halle, Germany.
-
Hofmann U
Department of Internal Medicine III, University Clinic Halle, Halle, Germany.
-
Ramos GC
Department of Internal Medicine III, University Clinic Halle, Halle, Germany.
Show more…
Published in:
- The Journal of clinical investigation. - 2019
English
T cell autoreactivity is a hallmark of autoimmune diseases but can also benefit self-maintenance and foster tissue repair. Herein, we investigated whether heart-specific T cells exert salutary or detrimental effects in the context of myocardial infarction (MI), the leading cause of death worldwide. After screening more than 150 class-II-restricted epitopes, we found that myosin heavy chain alpha (MYHCA) was a dominant cardiac antigen triggering post-MI CD4+ T cell activation in mice. Transferred MYHCA614-629-specific CD4+ T (TCR-M) cells selectively accumulated in the myocardium and mediastinal lymph nodes (med-LN) of infarcted mice, acquired a Treg phenotype with a distinct pro-healing gene expression profile, and mediated cardioprotection. Myocardial Treg cells were also detected in autopsies from patients who suffered a MI. Noninvasive PET/CT imaging using a CXCR4 radioligand revealed enlarged med-LNs with increased cellularity in MI-patients. Notably, the med-LN alterations observed in MI patients correlated with the infarct size and cardiac function. Taken together, the results obtained in our study provide evidence showing that MI-context induces pro-healing T cell autoimmunity in mice and confirms the existence of an analogous heart/med-LN/T cell axis in MI patients.
-
Language
-
-
Open access status
-
green
-
Identifiers
-
-
Persistent URL
-
https://sonar.ch/global/documents/621
Statistics
Document views: 84
File downloads: